Benzinga | May 6, 2021 04:38PM EDT

Eiger BioPharmaceuticals Q1 EPS $0.85 Up From $(0.62) YoY, Sales $3.60M

Eiger BioPharmaceuticals (NASDAQ:EIGR) reported quarterly earnings of $0.85 per share. This is a 237.1 percent increase over losses of $(0.62) per share from the same period last year. The company reported $3.60 million in sales this quarter.